Access Denied

Access Denied You don’t have permission to access “http://www.ndtv.com/india-news/southern-states-to-benefit-despite-smaller-population-sources-on-quota-bill-11358066” on this server. Reference #18.4b78ce17.1776192132.23cde752 https://errors.edgesuite.net/18.4b78ce17.1776192132.23cde752 Source link

Read More

Paytm ownership shift: Domestic investors cross 50% stake; firm turns majority Indian-controlled

One 97 Communications Ltd, which operates the Paytm brand, has become a majority Indian-owned and controlled company after domestic investors raised their stake to 50.3% as of March-end 2026, PTI reported.The shift marks a structural change in ownership for the fintech firm, with domestic shareholding rising steadily in recent quarters, reflecting growing investor confidence.Domestic institutional…

Read More

Gorillaz frontman Damon Albarn recalls a memory with Asha Bhosle that will last forever: ‘Her voice was my gateway to Bollywood’ |

As tributes continue to pour in for legendary singer Asha Bhosle, who passed away on April 12, global artist Damon Albarn has joined voices across the world in remembering the icon whose music transcended generations and borders. Taking to Instagram on Tuesday, Damon Albarn shared a heartfelt note along with a series of old photographs,…

Read More

Sergio Garcia apologizes for slamming club, breaking driver in Masters meltdown: ‘I regret the way I acted’

Sergio Garcia knows he took things too far at the 2026 Masters. Garcia reportedly received a code of conduct warning after damaging a tee box and breaking his driver after an errant tee shot Sunday. Two days later, Garcia issued an apology for his actions, admitting they have “no place in our game.” Advertisement His…

Read More

`Indian pharma must balance generics with innovation’

NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…

Read More